ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Donor Macrophage Depletion from CMV-Latently Infected Hearts Abrogates CMV-Accelerated Chronic Rejection.

J. Burg,1 T. Andoh,2 N. Haese,2 I. Jones,2 S. Orloff,1 D. Streblow.2

1Department of Surgery, OHSU, Portland, OR
2VGTI, OHSU, Hillsboro, OR

Meeting: 2017 American Transplant Congress

Abstract number: B27

Keywords: Cytomeglovirus, Heart, Rejection

Session Information

Session Name: Poster Session B: Acute and Chronic Rejection

Session Type: Poster Session

Date: Sunday, April 30, 2017

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Purpose: Latent donor CMV infection has been shown to accelerate chronic rejection (CR) in a heterotopic rat heart transplant model. CMV latency is associated with an influx of macrophages (macs) and T cells into cardiac tissue. We sought to determine whether the depletion of macs from CMV+ donor allografts using clodronate-laden liposomes would reduce CR.

Methods: Male F344 rats were infected with Rat CMV (RCMV) 9 months prior to organ procurement to establish latent RCMV infection. Three days prior to organ procurement donor rats were treated with PBS, liposomes or clodronate (n=10 rats/group). Mac depletion was confirmed by flow cytometry and immunohistochemistry. Donor hearts from the treated rats were heterotopically transplanted into CMV-naïve Lewis recipients. Post-op treatment with Cyclosporine prevented acute rejection. The time to rejection and extent of graft vasculopathy was monitored. CMV reactivation was assessed by antibody seroconversion and viral load at the time of rejection.

Results:

Clodronate treatment resulted in the depletion of tissue resident macs but not T or B cells from latently infected hearts. Treatment significantly delayed the mean time to graft rejection from 61 days to 84 days post transplant (p=0.002; Figure 1), and reduced the severity of graft vessel disease. Macrophage depletion did not affect recipient seroconversion as all recipients seroconverted to CMV after transplant.

Conclusions: Our study represents a novel approach to the pre-transplant treatment of donors. Donor macrophage depletion with clodronate liposomes resulted in delayed CMV-mediated accelerated CR and reduced graft vascular disease. Clodronate treatment did not prevent recipient CMV infection suggesting mechanisms independent of direct viral pathogenesis.

CITATION INFORMATION: Burg J, Andoh T, Haese N, Jones I, Orloff S, Streblow D. Donor Macrophage Depletion from CMV-Latently Infected Hearts Abrogates CMV-Accelerated Chronic Rejection. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Burg J, Andoh T, Haese N, Jones I, Orloff S, Streblow D. Donor Macrophage Depletion from CMV-Latently Infected Hearts Abrogates CMV-Accelerated Chronic Rejection. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/donor-macrophage-depletion-from-cmv-latently-infected-hearts-abrogates-cmv-accelerated-chronic-rejection/. Accessed May 9, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences